SCHEMBL3035959

SCHEMBL3035959

Cc1cc2c(cc1N(C)C)Nc1cc(N(C)C)ccc1S2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.36
▸ NOX1 Q9Y5S8 12/20 0.36
▸ GAA P10253 4/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ BCHE P06276 2/20 0.34
▸ ACHE P22303 2/20 0.34
▸ SNCA P37840 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ CYBB P04839 2/20 0.33
▸ NOX3 Q9HBY0 2/20 0.33
▸ NOX4 Q9NPH5 2/20 0.33
▸ ALOX15 P16050 2/20 0.33
▸ APP P05067 1/20 0.33
▸ CRHR1 P34998 1/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3035317 0.85 NOX1 (0.43) MAPTNOX1GAAMAPK1NPC1
SCHEMBL11765386 0.80 NOX1 (0.36) MAPTNOX1GAAMAPK1NPC1
SCHEMBL10476547 0.75 TERT (0.39) MAPTNOX1GAAMAPK1NPC1
Hydromethylthionine SCHEMBL12592446 0.75 SNCA (0.50) MAPTNOX1GAAMAPK1NPC1
Hydromethylthionine SCHEMBL109756 0.75 SNCA (0.50) MAPTNOX1GAAMAPK1NPC1
Hydromethylthionine SCHEMBL29356148 0.75 SNCA (0.50) MAPTNOX1GAAMAPK1NPC1
Hydrochloric Acid SCHEMBL735161 0.74 APAF1 (0.46) MAPTNOX1GAAMAPK1NPC1
Hydrochloric Acid SCHEMBL28617143 0.74 APAF1 (0.46) MAPTNOX1GAAMAPK1NPC1
Hydromethylthionine SCHEMBL25199191 0.73 SNCA (0.48) MAPTNOX1GAAMAPK1NPC1
Hydromethylthionine SCHEMBL1577040 0.73 SNCA (0.48) MAPTNOX1GAAMAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2185531-B1 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEV P H D (FR) 2012-07-25 — — EP claimed
US-20100204215-A1 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) 2010-08-12 — — US claimed
EP-2185531-A2 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF Pharma Hydro Development - P.H.D. (FR) 2010-05-19 — — EP claimed
WO-2009044054-A2 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) 2009-04-09 — — WO claimed
US-9067900-B2 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEVELOPMENT—P.H.D. (FR) 2015-06-30 — — US disclosed
US-9067900-B2 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEVELOPMENT—P.H.D. (FR) 2015-06-30 — — US disclosed
US-9067900-B2 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEVELOPMENT—P.H.D. (FR) 2015-06-30 — — US disclosed
EP-2185531-B1 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEV P H D (FR) 2012-07-25 — — EP disclosed
EP-2185531-B1 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEV P H D (FR) 2012-07-25 — — EP disclosed
US-20100204215-A1 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) 2010-08-12 — — US disclosed
US-20100204215-A1 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) 2010-08-12 — — US disclosed
US-20100204215-A1 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) 2010-08-12 — — US disclosed
WO-2009044054-A2 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) 2009-04-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204215-A1 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF AOC1, DDT, DDC MAPT 847/4885NOX1 143/4885GAA 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback